Uni-Bio Science Group Ltd. has announced the extension of two existing loan agreements with its connected parties, Guangzhou Taili Biomedical Technology Co., Limited and Dongguan Taili. The loans, originally maturing on 31 December 2025 and bearing an interest rate of 3.1% per annum, will continue under revised terms following arm’s length negotiations referencing prevailing market rates. The GZ Loan, extended to Guangzhou Taili, remains secured by a pledge over two invention patents held by the borrower. The lender, Beijing Genetech Pharmaceutical Co., Limited, is an indirect wholly-owned subsidiary of Uni-Bio Science Group. The company’s board, excluding interested directors, considers the extension terms to be fair and in the best interests of shareholders. All accrued interest on the GZ Loan up to the original maturity date has been paid in advance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Uni-Bio Science Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251229-11968573), on December 29, 2025, and is solely responsible for the information contained therein.
